In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Reliant Pharmaceuticals closes Series D financing

Executive Summary

Reliant Pharmaceuticals (sells ethical pharmaceuticals in primary care and specialty markets) closed a Series D private placement of convertible preferred units in which it raised $78mm. Several previous investors also exchanged secured debt, worth $37mm, for the units. Invemed Catalyst Fund led the round, followed by Bay City Capital Fund III, the Pritzker family businesses, BayStar Capital, and Reliant chairman and CEO Ernest Mario's family interests.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies